Decentralized Clinical Trials: Implementation of a Hybrid Model From a Site and Sponsor Perspective During Upcoming Webinar Hosted by Xtalks

TORONTO, Nov. 15, 2021 /PRNewswire-PRWeb/ -- Running decentralized clinical trials (DCTs) is a new and complex challenge for most stakeholders within the pharmaceutical industry. There are a lot of theoretical discussions and multiple approaches to conducting DCTs, but it's most useful to see how they are implemented from a real operational perspective. What is the impact on the patients? What is their perspective? Is it possible to create a simple, effective, and feasible approach to DCTs?

This webinar Decentralized Clinical Trials: Implementation of a Hybrid Model from a Site and Sponsor Perspective will focus on discussing the flexible tools necessary for adapting work to a number of different clinical trial models, including site-based, hybrid and virtual trials.

The speakers will answer the key questions during the speech, e.g.:

•     What are the challenges of DCTs for sites and sponsors?
•     What are the new roles for sites and PIs (e.g., patient oversight, assistance, and home visits)?
•     How can staff better meet the needs of patients through DCTs (e.g., improving access to trials, patient journey and retention)?
•     How will DCTs change the collaboration between sponsors, PIs and sites?

All participants, who register for this webinar will learn how to solve some of the most common challenges of running DCTs to ensure the needs of patients, sites and sponsors are met.

They will take part in the webinar: Dr. Ole Dammann, CEO, kfgn I Site Operations & Services, and Board Member, Country Head Germany, Pratia S.A.; Karl-Ludwig Radek, Internal Project Lead for IMI TRials@Home, The Janssen Pharmaceutical Companies of Johnson & Johnson; and Michał Kwiatek, MD, PhD, Investigator, Site Director, Pratia S.A.

Live webinar is being organized on Thursday, December 2, 2021 at 10am EST (3pm GMT/UK).

More information and register for this event on page: Decentralized Clinical Trials: Implementation of a Hybrid Model from a Site and Sponsor Perspective.

ABOUT PRATIA

Pratia is a platform for innovative medicine which offers the best mix of sites, expertise and access to patients for each protocol, as well as close collaboration with the local healthcare systems. We are a research organization platform that brings tech-savvy, adaptable solutions for innovative treatments at your convenience. With 90+ centers across 6 countries in Europe, and 700+ Clinical Trials carried out since 2012, we strive to connect patients & professionals via our platform in order to create better access to innovative care. We can conduct studies within 30+ therapeutical areas at the convenience of our Patients, Partners, and Physicians. We can address the dynamically changing requirements in the industry, including remote monitoring and decentralized studies.

More about Pratia: https://pratia.com/

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

More about Xtalks: http://xtalks.com
Information about hosting a webinar: http://xtalks.com/why-host-a-webinar/

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]

SOURCE Xtalks